| Identification | Back Directory | [Name]
INDEX NAME NOT YET ASSIGNED | [CAS]
2374122-27-5 | [Synonyms]
PROTAC IRAK4 degrader-2
1-{[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-4-{3-[9-(5-{[(2S)-1-[(2S,4R)-4-hydroxy-2-({[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl}carbamoyl)pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]carbamoyl}pyrimidin-2-yl)-3,9-diazaspiro[5.5]undecan-3-yl]prop-1-yn-1-yl}-7-methoxyisoquinoline-6-carboxamide | [Molecular Formula]
C57H68FN11O8S | [MOL File]
2374122-27-5.mol | [Molecular Weight]
1086.29 |
| Hazard Information | Back Directory | [Uses]
PROTAC IRAK4 degrader-2 (Compound 9) is a PROTAC-based IRAK4 degrader that affords potent IRAK4 degradation with a DC50 in peripheral blood mononuclear cells (PBMCs) cells of 151 nM. PROTAC IRAK4 degrader-2 induce a reduction of IRAK4 protein levels with a DC50 of 36 nM in PBMC cells. PROTAC IRAK4 degrader-2 also leads to the inhibition of multiple cytokines in PBMCs[1]. | [IC 50]
IRAK4 | [References]
[1] Joao Nunes, et al. Targeting IRAK4 for Degradation with PROTACs. ACS Med Chem Lett. 2019 Jun 14;10(7):1081-1085. DOI:10.1021/acsmedchemlett.9b00219 |
|
|